Claritev Corp (CTEV) posts its highest quarterly revenue in 17 quarters, lifts full-year 2026 outlook and now expects at least $1.1 billion in 2027 revenue a year ahead of plan.
Detailed price information for Stryker Corp (SYK-N) from The Globe and Mail including charting and trades.
Claritev shows early turnaround with revenue/bookings growth; Buy rating and $34 target (+40%). Click here to read this most recent analysis of CTEV stock.
MCLEAN, Va., September 22, 2026--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, has been selected by General Dynamics Information Technology (GDIT) to support the World Trade Center (WTC) Health Program. The WTC Health Program is a limited federal health care program established under the James Zadroga 9/11 Health and Compensation Act of 2010 (Extended in 2015). It provides nationw
MCLEAN, Va., September 17, 2026--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a healthcare technology, data, and insights company, today announced the publication of its 2025 Corporate Responsibility Report.
Detailed price information for Claritev Corporation (CTEV-N) from The Globe and Mail including charting and trades.
MCLEAN, Va., September 10, 2026--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable and transparent for all, today announced that Claritev Cares, its nonprofit foundation focused on expanding access to healthcare, has awarded its 2026 Rural Health Grants to Fairfield Memorial Hospital in Fairfield, Illinois, and Kodiak Community Health Center in Kodiak, Alaska.
On August 7, Claritev Corporation (NYSE:CTEV) reported second-quarter results that beat its own targets, marking five consecutive quarters of year-over-year revenue growth. Revenue for the quarter ended June 30 climbed 6.6% to $257.5 million, and management used the momentum to raise full-year guidance for the second time this year. The number that matters most, though, […]
MCLEAN, Va., August 27, 2026--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a healthcare technology, data, and insights company, today announced that members of its management team will meet with investors at the following events in September 2026:
This is the newest page. Registered accounts read further back.